Ledger.Open graph →
SEC Form D · filed March 18, 2026

NurExone Biologic Inc

Offering
$280K
Sold
$280K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
TECHNION CITY, HAIFA, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Aaron Wallace · Phoenix, AZExec · DirectorSean E. Foster · San Juan, Puerto RicoExec · DirectorWeston Reynolds · New York, NYExecDavid Cohen · Phoenix, AZDirectorByron Marchant · Phoenix, AZDirectorEyal Gabbai · Technion City, Haifa, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗